INVA Stock: Price, Earnings History and SEC Filings
Innoviva, Inc. (INVA) last traded at $21.22, down 0.42% on the latest session and up 0.0% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.59 against an analyst estimate of $0.56, a beat of 5.4%.
$21.22 -0.42%
1 month+0.05%
52-week high$25.15
52-week low$17.84
Volume623,267
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
INVA earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $0.59 | $0.56 | +5.36% |
| Mar 2026 | May 6, 2026 | $0.44 | $0.43 | +2.33% |
| Dec 2025 | Feb 25, 2026 | $1.94 | $0.34 | +470.59% |
| Sep 2025 | Nov 5, 2025 | $1.08 | $0.46 | +134.78% |
INVA beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for INVA
SEC filing data is not available right now. You can search for INVA on SEC EDGAR.
INVA news
- AbbVie (ABBV) Tops Q3 Earnings and Revenue EstimatesOct 30, 2026 · finance.yahoo.com
- Eli Lilly (LLY) Surpasses Q3 Earnings and Revenue EstimatesOct 29, 2026 · finance.yahoo.com
- Innoviva Specialty Therapeutics to Present Data Across Infectious Disease Portfolio at IDWeek 2026Oct 19, 2026 · finance.yahoo.com
About Innoviva, Inc.
Innoviva, Inc. (INVA) is a US-listed public company on Nasdaq.